POLR2A and cancer: In cancer, POLR2A is frequently overexpressed across tumor types, including breast (Xu et al., 2019), lung (Zeng et al., 2021), colon carcinomas (Liu et al., 2015), and glioblastomas (Wei et al., 2019).